U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. FDA Grand Rounds
  1. About Science & Research at FDA

FDA Grand Rounds

FDA Grand Rounds

The FDA Grand Rounds is an educational presentation that is webcast monthly to highlight cutting-edge research underway across the Agency and its impact on protecting and advancing public health. Each session features an FDA scientist presenting on a key public health challenge and how FDA is applying science to its regulatory activities. The 45-minute educational presentation is followed by questions from the audience. You can also view the presentation under Past Grand Rounds following the live webcast. #FDAGrandRounds.

Upcoming Event

FDA Grand Rounds - Salmonella and Escherichia coli: Challenges Along the One Health Continuum

Thursday, July 11, 2024
12:00 p.m. - 1:00 p.m. ET
Webcast 

About the Speaker

Steven Foley, Ph.D.
Senior Biomedical Research and Biomedical Product Assessment Service (SBRBPAS) Expert and Director, Division of Microbiology
National Center for Toxicological Research (NCTR) 
Office of the Chief Scientist (OCS)
Office of the Commissioner (OC)

Dr. Steven Foley is a Senior Biological Research and Biological Product Assessment Service (SBRBPAS) Expert and Director of the Division of Microbiology at FDA’s National Center for Toxicological Research (NCTR). Dr. Foley earned a Bachelor of Science degree in zoology and a Ph.D. in cellular and molecular biology/infectious diseases from North Dakota State University and completed a postdoctoral fellowship with FDA’s Center for Veterinary Medicine, where the focus of his research was on developing methods for source tracking of Salmonella from food-animal species.  At NCTR, Dr. Foley’s direct research team has been focused on the fields of zoonotic diseases, food safety, and the microbiology of FDA-regulated products.

Past Grand Rounds

2024

2023

2022

2021

2020

2019

2018

2017

2016

Resources For You


Sub-Topic Paragraphs

Latest From the Commissioner

Remarks by Dr. Califf and Dr. Bumpus at the FDA Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees - 06/13/2024

Jun 13

Combatting The Youth Vaping Epidemic By Enhancing Enforcement Against Illegal E-Cigarettes - 06/12/2024

Jun 12

Remarks by Commissioner Califf to the 2024 FDA Regulatory Education for Industry Annual Conference (REdI) - 05/29/2024

May 29

Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices - 05/22/2024

May 22

FDA Statement from Todd Simpson, FDA Chief Information Officer (CIO) on GAO Report Regarding FDA’s IT Security Program

Sep 29

Statement by FDA Commissioner Scott Gottlieb, M.D. on new steps by FDA to advance patient engagement in the agency’s regulatory work

Feb 28

Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation

Dec 07

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Jun 12


Back to Top